Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Session Type:

Availability:

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 46 of 46
INTERACTIVE MODERATOR
Adaora Adimora
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
INTERACTIVE MODERATOR
Carlos del Rio
Emory University, Atlanta, GA, USA
VACCINE MANDATES: HISTORY IN THE UNITED STATES AND OTHER COUNTRIES
Ruth Macklin
Albert Einstein College of Medicine, Pittsburgh, PA, USA
VACCINE HESITANCY AMONG MEMBERS OF RACIAL AND ETHNIC MINORITY GROUPS
Matifadza Hlatshwayo Davis
City of St Louis Department of Health, Saint Louis, MO, USA
LEGAL AND POLITICAL ISSUES RELATED TO VACCINE MANDATES IN THE US, AND SOLUTIONS FOR OVERCOMING THEM
Lawrence O Gostin
Georgetown University, Washington, MD, USA
LIVE PANEL DISCUSSION WITH AUDIENCE QUESTIONS AND ANSWERS
Carlos del Rio
Emory University, Atlanta, GA, USA
LIVE PANEL DISCUSSION WITH AUDIENCE QUESTIONS AND ANSWERS
Adaora Adimora
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
from CROI 2022 on February 14, 2022 12:00 PM-1:00 PM
INTERACTIVE MODERATOR
Rajesh Tim Gandhi
Massachusetts General Hospital, Boston, MA, USA
Ghady Haidar
University of Pittsburgh, Pittsburgh, PA, USA
INTERACTIVE MODERATOR
Annie Luetkemeyer
University of California San Francisco, San Francisco, CA, USA
Laura E Riley
Weill Cornell Medicine, New York, NY, USA
David Lye
National Centre for Infectious Diseases, Singapore, Singapore
Sandra Wagner-Cardoso
Instituto de Pesquisa Clinica Evandro Chagas, Rio de Janeiro, Brazil
CASE 1: AN IMMUNOCOMPROMISED PATIENT WITH HIV AND COVID-19
CASE 2: A PREGNANT WOMAN WITH MODERATE TO SEVERE COVID-19
CASE 3: A FULLY VACCINATED AND BOOSTED PATIENT WHO IS OPEN TO COVID-19 PREP
from CROI 2022 on February 14, 2022 12:00 PM-1:00 PM
SESSION OVERVIEW
Douglas D Richman
University of California San Diego, La Jolla, CA, USA
SESSION OVERVIEW
Guido Silvestri
Emory University, Atlanta, GA, USA
UNIQUE CHALLENGES OF VACCINATING DURING A PANDEMIC
John P Moore
Weill Cornell Medical College, New, NY, USA
HPV VACCINE: A SUCCESSFUL MODEL OF VACCINE-INDUCED MUCOSAL ANTIVIRAL IMMUNE RESPONSE
Margaret A Stanley
Retired, Cambridge, United Kingdom
FLU VACCINES: THE GLASS HALF-FULL
Florian Krammer
Icahn School of Medicine at Mount Sinai, New York, NY, USA
HERPES VIRUSES: VIRUSES THAT EVADE VACCINE-INDUCED HOST-IMMUNE RESPONSES
Betsy Herold
Albert Einstein College of Medicine, Bronx, NY, USA
HIV-1: THE ULTIMATE CHALLENGE FOR VACCINE DEVELOPMENT
Alexandra Trkola
University of Zurich, Zurich, Switzerland
LIVE PANEL DISCUSSION WITH AUDIENCE QUESTIONS AND ANSWERS
from CROI 2022 on February 14, 2022 12:00 PM-1:00 PM
SESSION OVERVIEW: PUTTING LONG COVID IN CONTEXT
Steven Grant Deeks
University of California San Francisco, Cloverdale, CA, USA
THEMES IN NEUROLOGY
Avindra Nath
National Institutes of Health, Bethesda, MD, USA
THEMES IN VIROLOGY
Susan R Weiss
University of Pennsylvania, Philadelphia, PA, USA
THEMES IN IMMUNOLOGY
Akiko Iwasaki
Yale University, New Haven, CT, USA
LIVE PANEL DISCUSSION WITH AUDIENCE QUESTIONS AND ANSWERS
Galit Alter
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
LIVE PANEL DISCUSSION WITH AUDIENCE QUESTIONS AND ANSWERS
David L Thomas
The Johns Hopkins School of Medicine, Baltimore, MD, USA
from CROI 2022 on February 15, 2022 12:00 PM-1:00 PM
SESSION OVERVIEW
Susan P Buchbinder
San Francisco Department of Public Health, San Francisco, CA, USA
SESSION OVERVIEW
Moses R Kamya
Makerere University College of Health Sciences, Kampala, Uganda
GLOBAL PREP UPTAKE IN ADOLESCENT GIRLS AND YOUNG WOMEN
Rachel Baggaley
World Health Organization, Geneva, Switzerland
EXPERIENCE WITH OFFERING PEP ALONGSIDE PREP
James Ayieko
Kenya Medical Research Institute, Nairobi, Kenya
PREP IMPLEMENTATION IN ADOLESCENT GIRLS AND YOUNG WOMEN
Nicolette Prea Naidoo
Wits Reproductive Health and HIV Institute, Johannesburg, South Africa
PREP IMPLEMENTATION IN YOUNG SEX WORKERS IN ZIMBABWE
Primrose Matambanadzo
Centre for Sexual Health and HIV/AIDS Research Zimbabwe, Harare, Zimbabwe
LIVE PANEL DISCUSSION WITH AUDIENCE QUESTIONS AND ANSWERS
Susan P Buchbinder
San Francisco Department of Public Health, San Francisco, CA, USA
LIVE PANEL DISCUSSION WITH AUDIENCE QUESTIONS AND ANSWERS
Moses R Kamya
Makerere University College of Health Sciences, Kampala, Uganda
from CROI 2022 on February 15, 2022 12:00 PM-1:00 PM
SESSION OVERVIEW
James Hoxie
University of Pennsylvania, Berwyn, PA, USA
SESSION OVERVIEW
Richard A Koup
National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
NEW AND IMPROVED T CELL CARS FOR HIV ERADICATION OR CONTROL
James L Riley
University of Pennsylvania, Philadelphia, PA, USA
GENERATING CAR T CELLS IN VIVO
Hans-Peter Kiem
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
NATURAL KILLER CELL CARS: NEW APPROACHES TO CURE LEUKEMIA AND LYMPHOMA
Katy Rezvani
MD Anderson Cancer Center, Houston, TX, USA
STIMULATING CARS WITH MRNA VACCINES
Benjamin Rengstl
BioNTech SE, Mainz, Germany
PANEL DISCUSSION
James Hoxie
University of Pennsylvania, Berwyn, PA, USA
PANEL DISCUSSION
Richard A Koup
National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
from CROI 2022 on February 16, 2022 12:00 PM-1:00 PM
SESSION OVERVIEW
TOO MANY, TOO LONG? - CASE PRESENTATION AND DISCUSSION
Timothy Wilkin
Weill Cornell Medicine, New York, NY, USA
SESSION WRAP-UP
INTRODUCTION OF EXPERT PANELISTS
Joseph J Eron
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
INTRODUCTION OF EXPERT PANELISTS
Natella Rakhmanina
Children's National Hospital, Washington, DC, USA
INTRODUCTION OF EXPERT PANELISTS
Hermione Lyall
Imperial College Healthcare NHS Trust, London, United Kingdom
INTRODUCTION OF EXPERT PANELISTS
Mina C Hosseinipour
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
INTRODUCTION OF EXPERT PANELISTS
Annemarie Wensing
University Medical Center Utrecht, Utrecht, Netherlands
INTRODUCTION OF EXPERT PANELISTS
Timothy Wilkin
Weill Cornell Medicine, New York, NY, USA
IS 'OUCH' THE ANSWER? - CASE PRESENTATION AND DISCUSSION
Mina C Hosseinipour
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
NINJA MUTANT DECADES? - CASE PRESENTATION AND DISCUSSION
Natella Rakhmanina
Children's National Hospital, Washington, DC, USA
from CROI 2022 on February 16, 2022 12:00 PM-1:00 PM
SESSION OVERVIEW
Monica Gandhi
University of California San Francisco, San Francisco, CA, USA
SESSION OVERVIEW
Jean-Michel Molina
University of Paris, Paris, France
ROLE OF VARIANTS AND VIRAL LOAD IN SARS-COV2 TRANSMISSION
Arnaud Fontanet
Institut Pasteur, Paris, France
IS SARS-COV-2 VIRAL LOAD ASSOCIATED WITH DISEASE PROGRESSION AND RESPONSE TO TREATMENT?
Matthew A Spinelli
University of California San Francisco, San Francisco, CA, USA
ARE NEW SARS COV-2 VARIANTS ASSOCIATED WITH MORE SEVERE DISEASE?
Fiona P. Havers
Centers for Disease Control and Prevention, Atlanta, GA, USA
VIRAL LOAD KINETICS IN PARTIALLY OR FULLY VACCINATED INDIVIDUALS INFECTED WITH SARS COV-2
Annelies Wilder-Smith
London School of Hygiene and Tropical Medicine, London, United Kingdom
LIVE PANEL DISCUSSION WITH AUDIENCE QUESTIONS AND ANSWERS
Monica Gandhi
University of California San Francisco, San Francisco, CA, USA
LIVE PANEL DISCUSSION WITH AUDIENCE QUESTIONS AND ANSWERS
Jean-Michel Molina
University of Paris, Paris, France
from CROI 2022 on February 16, 2022 12:00 PM-1:00 PM
SESSION OVERVIEW
Peter W Hunt
University of California San Francisco, San Francisco, CA, USA
Grace A McComsey
University Hospitals Cleveland Medical Center, Cleveland, OH, USA
Sadaf Farooqi
Cambridge University, Cambridge, United Kingdom
Jane O'Halloran
Washington University in St Louis, St Louis, MO, USA
Cissy M Kityo
Joint Clinical Research Centre, Lubowa, Uganda
from CROI 2021 on March 8, 2021 1:30 PM-2:30 PM
SESSION OVERVIEW
Wafaa M El-Sadr
Columbia University, New York, NY, USA
from CROI 2021 on March 8, 2021 1:30 PM-2:30 PM
THE ROLE OF CONTACT TRACING IN EPIDEMIC CONTROL: FACILITATORS AND BARRIERS
Chi-Chi N. Udeagu
New York City Department of Health and Mental Hygiene, Queens, NY, USA
from CROI 2021 on March 8, 2021 1:30 PM-2:30 PM
CONTACT TRACING FOR HIV AND SEXUALLY TRANSMITTED INFECTIONS
Matthew R Golden
University of Washington, Seattle, WA, USA
from CROI 2021 on March 8, 2021 1:30 PM-2:30 PM
CONTACT TRACING GOES VIRAL: VALUE AND ETHICS OF DIGITAL CONTACT TRACING
Jeffrey Kahn
Johns Hopkins University, Baltimore, MD, USA
from CROI 2021 on March 8, 2021 1:30 PM-2:30 PM
MODERATED DISCUSSION WITH QUESTIONS AND ANSWERS FROM THE AUDIENCE
Wafaa M El-Sadr
Columbia University, New York, NY, USA
Chi-Chi N. Udeagu
New York City Department of Health and Mental Hygiene, Queens, NY, USA
Matthew R Golden
University of Washington, Seattle, WA, USA
Jeffrey Kahn
Johns Hopkins University, Baltimore, MD, USA
from CROI 2021 on March 8, 2021 1:30 PM-2:30 PM
SESSION OVERVIEW
Katharine J Bar
University of Pennsylvania, Philadelphia, PA, USA
John M Coffin
Tufts University, Medford, MA, USA
from CROI 2021 on March 8, 2021 1:30 PM-2:30 PM
HIV-1 ENV AND SARS-COV-2 SPIKE EVOLUTION: SIMILARITIES AND DIFFERENCES
Bette Korber
Los Alamos National Laboratory, Los Alamos, NM, USA
from CROI 2021 on March 8, 2021 1:30 PM-2:30 PM
SARS-COV-2 EVOLUTION AT THE POPULATION LEVEL
Morgane Rolland
Walter Reed Army Institute of Research, Silver Spring, MD, USA
from CROI 2021 on March 8, 2021 1:30 PM-2:30 PM
STRUCTURE AND FUNCTION OF SARS-COV-2 SPIKE PROTEIN VARIANTS
Jeremy Luban
University of Massachusetts Medical School, Worcester, MA, USA
from CROI 2021 on March 8, 2021 1:30 PM-2:30 PM
SELECTION OF NEUTRALIZATION RESISTANT SARS-COV-2 MUTANTS
Paul Bieniasz
The Rockefeller University, New York, NY, USA
from CROI 2021 on March 8, 2021 1:30 PM-2:30 PM
ANTIBODY IMMUNITY TO SARS-COV-2 501Y.V2 THROUGH VACCINATION AND INFECTION
Penny Moore
University of Witwatersrand, Johannesburg, South Africa
from CROI 2021 on March 8, 2021 1:30 PM-2:30 PM
PANEL DISCUSSION
from CROI 2021 on March 8, 2021 1:30 PM-2:30 PM
SESSION OVERVIEW
Carlos del Rio
Emory University, Atlanta, GA, USA
Diane V Havlir
University of California San Francisco, San Francisco, CA, USA
Francois Venter
Ezintsha, Johannesburg, South Africa
Nittaya Phanuphak
Institute of HIV Research and Innovation, Bangkok, Thailand
Charles W Flexner
Johns Hopkins University, Baltimore, MD, USA
Hyman Scott
San Francisco Department of Public Health, San Francisco, CA, USA
from CROI 2021 on March 9, 2021 1:30 PM-2:30 PM
SESSION OVERVIEW
Galit Alter
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA
Guido Silvestri
Emory University, Atlanta, GA, USA
from CROI 2021 on March 9, 2021 1:30 PM-2:30 PM
HUMORAL RESPONSES AGAINST THE SARS-COV-2 SPIKE
Andrés Finzi
Université de Montréal, Montreal, Canada
from CROI 2021 on March 9, 2021 1:30 PM-2:30 PM
T CELL IMMUNITY IN SARS-COV-2 NATURAL INFECTION AND FOLLOWING VACCINATION
Julie McElrath
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
from CROI 2021 on March 9, 2021 1:30 PM-2:30 PM
LONGITUDINAL ANTIBODY RESPONSES TO SARS-COV-2 AND EMERGING VARIANTS
Katie J Doores
King's College London, London, United Kingdom
from CROI 2021 on March 9, 2021 1:30 PM-2:30 PM
PROGRAMMING DURABLE IMMUNITY
Robert Seder
Vaccine Research Center, Bethesda, MD, USA
from CROI 2021 on March 9, 2021 1:30 PM-2:30 PM
PATHOLOGICAL B CELL ACTIVATION DURING SARS-COV-2 INFECTION
Ignacio Sanz
Emory University, Atlanta, GA, USA
from CROI 2021 on March 9, 2021 1:30 PM-2:30 PM
SETTING THE STAGE: UNAIDS 2030 GOALS AND CURRENT STATE OF THE EPIDEMIC
Sheena McCormack
University College London, London, United Kingdom
from CROI 2021 on March 9, 2021 1:30 PM-2:30 PM
CHALLENGES TO PREP SCALE-UP
Mark Dybul
Georgetown University, Washington, DC, USA
from CROI 2021 on March 9, 2021 1:30 PM-2:30 PM
PREP IMPLEMENTATION IN SUB-SAHARAN AFRICA
Elizabeth Irungu
Jomo Kenyatta University of Agriculture and Technology, NAIROBI, Kenya
from CROI 2021 on March 9, 2021 1:30 PM-2:30 PM
INTERACTIVE DISCUSSION
Mark Dybul
Georgetown University, Washington, DC, USA
Sheena McCormack
University College London, London, United Kingdom
Elizabeth Irungu
Jomo Kenyatta University of Agriculture and Technology, NAIROBI, Kenya
from CROI 2021 on March 9, 2021 1:30 PM-2:30 PM
WELCOME AND SESSION OVERVIEW
Roy M Gulick
Weill Cornell Medicine, New York, NY, USA
Karine Lacombe
Sorbonne Université, Paris, France
Paul E Sax
Brigham and Women's Hospital, Boston, MA, USA
Zarir F Udwadia
Hinduja Hospital and Medical Research Center, Mumbai, India
Claudia P. Cortes
University of Chile, Santiago, Chile
from CROI 2021 on March 10, 2021 1:30 PM-2:30 PM
SESSION OVERVIEW
Monica Gandhi
University of California San Francisco, San Francisco, CA, USA
from CROI 2021 on March 10, 2021 1:30 PM-2:30 PM
DISPARITIES IN COVID-19 AMONG RACIAL AND ETHNIC MINORITIES IN THE US
Mary T Bassett
Harvard T.H. Chan School of Public Health, Boston, MA, USA
from CROI 2021 on March 10, 2021 1:30 PM-2:30 PM
DISPARITIES IN COVID-19 IN NATIVE AMERICAN COMMUNITIES
David R Wilson
National Institutes of Health, Bethesda, MD, USA
from CROI 2021 on March 10, 2021 1:30 PM-2:30 PM
INCARCERATED POPULATIONS AND COVID-19
Robert E Fullilove
Columbia University Medical Center, New York, NY, USA
from CROI 2021 on March 10, 2021 1:30 PM-2:30 PM
MODERATED DISCUSSION
Mary T Bassett
Harvard T.H. Chan School of Public Health, Boston, MA, USA
Monica Gandhi
University of California San Francisco, San Francisco, CA, USA
Robert E Fullilove
Columbia University Medical Center, New York, NY, USA
David R Wilson
National Institutes of Health, Bethesda, MD, USA
from CROI 2021 on March 10, 2021 1:30 PM-2:30 PM
SESSION OVERVIEW
Nicolas Chomont
Université de Montréal, Montreal, Canada
Richard A Koup
National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
from CROI 2021 on March 10, 2021 1:30 PM-2:30 PM
PANEL DISCUSSION
from CROI 2021 on March 10, 2021 1:30 PM-2:30 PM
SARS-COV-2 DEBRIS AND ITS CONTRIBUTION TO COVID-19
Benjamin tenOever
Icahn School of Medicine at Mount Sinai, New York, NY, USA
from CROI 2021 on March 10, 2021 1:30 PM-2:30 PM
TOWARD SWEET THERAPIES FOR SOUR IMMUNOPATHOLOGIES IN COVID-19
Catherine A Blish
Leland Stanford Junior University, Stanford, CA, USA
from CROI 2021 on March 10, 2021 1:30 PM-2:30 PM
AFUCOSYLATED IGG RESPONSES AND SEVERITY IN COVID-19
Gestur Vidarsson
Sanquin Research/University of Amsterdam, Amsterdam, Netherlands
from CROI 2021 on March 10, 2021 1:30 PM-2:30 PM
ANTICIPATING ESCAPE PATHWAYS FOR SARS-COV-2
Julie Overbaugh
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
from CROI 2021 on March 10, 2021 1:30 PM-2:30 PM
THE SPECTRUM OF T CELL RESPONSES TO SARS-COV-2
Marcus Buggert
Karolinska Institutet, Huddinge, Sweden
from CROI 2021 on March 10, 2021 1:30 PM-2:30 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 46 of 46